Log in to save to my catalogue

Investigation of Serum Endocan Levels in SARS-CoV-2 Patients

Investigation of Serum Endocan Levels in SARS-CoV-2 Patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10932032

Investigation of Serum Endocan Levels in SARS-CoV-2 Patients

About this item

Full title

Investigation of Serum Endocan Levels in SARS-CoV-2 Patients

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2024-03, Vol.25 (5), p.3042

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Endocan is an endothelial-cell-specific proteoglycan (ESM-1) and has emerged as an endothelial dysfunction and inflammatory marker in recent years. Endocan can be used as a marker of inflammatory endothelial dysfunction in endothelium-dependent disease: cardiovascular disease, sepsis, lung and kidney disease and malignancies. Recent data suggest th...

Alternative Titles

Full title

Investigation of Serum Endocan Levels in SARS-CoV-2 Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10932032

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10932032

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms25053042

How to access this item